Cargando…

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy

SIMPLE SUMMARY: Diverse evidence revealed that CD4(+) T cells play an important role in antitumor immunity by promoting or suppressing cytotoxic T cell responses. This review outlines the role of CD4(+) T subsets within the tumor microenvironment and summarizes the latest progress regarding their po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Khelil, Myriam, Godet, Yann, Abdeljaoued, Syrine, Borg, Christophe, Adotévi, Olivier, Loyon, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750687/ https://www.ncbi.nlm.nih.gov/pubmed/35008422 http://dx.doi.org/10.3390/cancers14010260

Ejemplares similares

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
por: Abdeljaoued, Syrine, et al.
Publicado: (2022)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Epigenetic Reprogramming of CD4(+) Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
por: Renaude, Elodie, et al.
Publicado: (2021)

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
por: Galaine, Jeanne, et al.
Publicado: (2015)

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
por: Kroemer, Marie, et al.
Publicado: (2020)

Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020)

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
por: Vienot, Angélique, et al.
Publicado: (2022)

CD8(+) CD226(high) T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery
por: Viot, Julien, et al.
Publicado: (2023)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2020)

Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
por: Loyon, Romain, et al.
Publicado: (2019)

Harnessing allogeneic CD4(+) T cells to reinvigorate host endogenous antitumor immunity
por: Mochizuki, Kazuhiro
Publicado: (2023)

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
por: Dosset, Magalie, et al.
Publicado: (2013)

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
por: Vrecko, Sindy, et al.
Publicado: (2018)

Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
por: Seyed, Negar, et al.
Publicado: (2014)

Harnessing the Microbiome to Enhance Cancer Immunotherapy
por: Nelson, Michelle H., et al.
Publicado: (2015)

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
por: Caël, Blandine, et al.
Publicado: (2022)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2019)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
por: Hannon, Gary, et al.
Publicado: (2023)

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice
por: Rangan, Laurie, et al.
Publicado: (2017)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment
por: Renaude, Elodie, et al.
Publicado: (2020)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy
por: Huang, Ziyin, et al.
Publicado: (2022)

The ATG8 Family Proteins GABARAP and GABARAPL1 Target Antigen to Dendritic Cells to Prime CD4(+) and CD8(+) T Cells
por: Fonderflick, Leïla, et al.
Publicado: (2022)

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015)

Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
por: Rajani, Karishma R., et al.
Publicado: (2019)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Harnessing immunological targets for COVID-19 immunotherapy
por: Mehata, Abhishesh Kumar, et al.
Publicado: (2021)

HOW TO HARNESS NEW IMMUNOTHERAPIES WITH COMBINATION STRATEGIES?
por: Einsele, H.
Publicado: (2023)

Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
por: Bae, Jihong, et al.
Publicado: (2022)

Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assays
por: Lipp, Clémentine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k1perp8qpl02gfat0ttk2qf3f1